Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News12 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General17 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging